High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy

BACKGROUND AND OBJECTIVES: Different rituximab protocols are used to treat membranous nephropathy. We compared two rituximab protocols in patients with membranous nephropathy. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Twenty-eight participants from the NICE cohort received two infusions of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin J Am Soc Nephrol
Autors principals: Seitz-Polski, Barbara, Dahan, Karine, Debiec, Hanna, Rousseau, Alexandra, Andreani, Marine, Zaghrini, Christelle, Ticchioni, Michel, Rosenthal, Alessandra, Benzaken, Sylvia, Bernard, Ghislaine, Lambeau, Gérard, Ronco, Pierre, Esnault, Vincent L.M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6682825/
https://ncbi.nlm.nih.gov/pubmed/31340979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.11791018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars